基于肝脾同调理论辨治甲状腺相关眼病眼眶减压术后症候群

Treatment of Post-Orbital Decompression Syndrome in Thyroid-Associated Ophthal⁃ mopathy Based on the Co-regulation of Liver and Spleen Theory

摘要:

甲状腺相关眼病（TAO） 属难治性眼眶疾患，眼眶减压术后常伴多种残余症状。本文着眼“肝脾 同调”理论，深入探讨TAO术后核心病机，提出“肝郁脾虚，痰湿互结”为其关键病理基础。治疗上，疏肝 健脾法贯穿TAO术后全程，早期辅以化痰散瘀，中期侧重补气活血，后期注重滋补肝肾，临床应用疏肝健脾 方治疗TAO眼眶减压术后症候群疗效肯定。

Abstract:

Abstract： Thyroid-associated ophthalmopathy （TAO） is a refractory orbital disease with multiple residual symptoms after orbital decompression. This paper focuses on the "co-regulation of liver and spleen" theory to explore the core pathogenesis of postoperative TAO， and propose that "liver depression， spleen deficiency， and phlegmdampness inter-conjugation" is the key pathological basis. Accordingly， the method of liver-soothing and spleeninvigorating was applied throughout the whole postoperative period of TAO. The treatment was divided into three stages： the early stage was supplemented by resolving phlegm and dispersing blood stasis， and the middle stage focused on tonifying qi and activating blood，and the late stage nourishing the liver and kidney. The clinical application of Shugan Jianpi Prescription has a definite curative effect on post-orbital decompression syndrome in TAO.